感染指南

订阅

MedSci主页 / 所有栏目 / 感染指南

2019 AST指南：病毒性肝炎

2019-02-28 美国移植学会 Clin Transplant. 2019 Feb 28:e13514.

病毒性肝炎

2019年2月，美国移植学会(AST)传染病实践委员会发布了病毒性肝炎指南，文章主要针对移植前和移植后病毒性肝炎的诊断，预防以及管理提出指导建议。

中文标题：

2019 AST指南：病毒性肝炎

英文标题：

Viral Hepatitis: Guidelines by the American Society of Transplantation Infectious Disease Community of Practice

发布机构：

美国移植学会

发布日期：

2019-02-28

简要介绍：

2019年2月，美国移植学会(AST)传染病实践委员会发布了病毒性肝炎指南，文章主要针对移植前和移植后病毒性肝炎的诊断，预防以及管理提出指导建议。 

拓展指南：与肝炎相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2019 AST指南：病毒性肝炎)] GetToolGuiderByIdResponse(projectId=1, id=2f9fc1c001e1a612, title=2019 AST指南：病毒性肝炎, enTitle=Viral Hepatitis: Guidelines by the American Society of Transplantation Infectious Disease Community of Practice, guiderFrom=Clin Transplant. 2019 Feb 28:e13514., authorId=null, author=, summary=2019年2月，美国移植学会(AST)传染病实践委员会发布了病毒性肝炎指南，文章主要针对移植前和移植后病毒性肝炎的诊断，预防以及管理提出指导建议。 , cover=, journalId=null, articlesId=null, associationId=741, associationName=美国移植学会, associationIntro=美国移植协会（American Society of Transplantation，AST）成立于1982年，一个超过3000名移植专家致力于研究，教育，移植的宣传和病人护理的组织。目标是提供一个在移植领域的科学信息和专业知识交流论坛。, copyright=0, guiderPublishedTime=Thu Feb 28 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<div>2019年2月，美国移植学会(AST)传染病实践委员会发布了病毒性肝炎指南，文章主要针对移植前和移植后病毒性肝炎的诊断，预防以及管理提出指导建议。 </div> <div><br> </div>拓展指南：<strong>与<font color=red>肝炎</font>相关指南：</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=f25831c001e08187" title="2019 共识指南：非酒精性脂肪性肝炎患者临床试验期间疑似急性药物性肝损伤的检测、评估和管理实践" target=_blank>2019 共识指南：非酒精性脂肪性肝炎患者临床试验期间疑似急性药物性肝损伤的检测、评估和管理实践</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=537431c001690e7d" title="《2018年国际肝移植协会意见：非酒精性脂肪性肝炎的管理和治疗》摘译" target=_blank>《2018年国际肝移植协会意见：非酒精性脂肪性肝炎的管理和治疗》摘译</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=d67fd1c0016836cc" title="2018 意大利共识建议：类风湿性关节炎丙型肝炎感染的管理" target=_blank>2018 意大利共识建议：类风湿性关节炎丙型肝炎感染的管理</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=a4efe1c0016e729b" title="2018 台湾共识声明：慢性乙型肝炎的管理" target=_blank>2018 台湾共识声明：慢性乙型肝炎的管理</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=49ee11c00166394d" title="2018 SEIMC共识文件：吸毒者丙型肝炎感染的管理" target=_blank>2018 SEIMC共识文件：吸毒者丙型肝炎感染的管理</a></li> 更多信息请点击：<a href="https://www.medsci.cn/guideline/list.do?q=%E8%82%9D%E7%82%8E" target=_blank>有关肝炎更多指南</a></ul>, tagList=[TagDto(tagId=657, tagName=病毒性肝炎)], categoryList=[CategoryDto(categoryId=9, categoryName=感染, tenant=100), CategoryDto(categoryId=22, categoryName=肝病, tenant=100), CategoryDto(categoryId=21060, categoryName=梅斯医学-病毒性肝炎网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=9433, appHits=635, showAppHits=1, pcHits=5617, showPcHits=4496, likes=106, shares=12, comments=3, approvalStatus=1, publishedTime=Mon Mar 18 22:30:36 CST 2019, publishedTimeString=2019-02-28, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Mon Mar 18 22:30:36 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 05:07:28 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 AST指南：病毒性肝炎)])
2019 AST指南：病毒性肝炎
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=882905, encodeId=b953882905bd, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200905/7f6b70ded6c34c43b284114c6ebb39cf/87383a81abf14df1b42b07def6ffb67f.jpg, createdBy=328c5246537, createdName=菲菲, createdTime=Sat Sep 05 11:48:26 CST 2020, time=2020-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812003, encodeId=0b838120033b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200905/7f6b70ded6c34c43b284114c6ebb39cf/87383a81abf14df1b42b07def6ffb67f.jpg, createdBy=328c5246537, createdName=147d0f16m43暂无昵称, createdTime=Sat Aug 22 11:04:22 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=363274, encodeId=69bc3632e4fe, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/20/4198703c655298b79c00e85cf201319b.jpg, createdBy=b7312567629, createdName=病猫, createdTime=Wed Mar 20 23:34:45 CST 2019, time=2019-03-20, status=1, ipAttribution=)]
    2020-09-05 菲菲

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=882905, encodeId=b953882905bd, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200905/7f6b70ded6c34c43b284114c6ebb39cf/87383a81abf14df1b42b07def6ffb67f.jpg, createdBy=328c5246537, createdName=菲菲, createdTime=Sat Sep 05 11:48:26 CST 2020, time=2020-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812003, encodeId=0b838120033b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200905/7f6b70ded6c34c43b284114c6ebb39cf/87383a81abf14df1b42b07def6ffb67f.jpg, createdBy=328c5246537, createdName=147d0f16m43暂无昵称, createdTime=Sat Aug 22 11:04:22 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=363274, encodeId=69bc3632e4fe, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/20/4198703c655298b79c00e85cf201319b.jpg, createdBy=b7312567629, createdName=病猫, createdTime=Wed Mar 20 23:34:45 CST 2019, time=2019-03-20, status=1, ipAttribution=)]
    2020-08-22 147d0f16m43暂无昵称

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=882905, encodeId=b953882905bd, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200905/7f6b70ded6c34c43b284114c6ebb39cf/87383a81abf14df1b42b07def6ffb67f.jpg, createdBy=328c5246537, createdName=菲菲, createdTime=Sat Sep 05 11:48:26 CST 2020, time=2020-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812003, encodeId=0b838120033b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200905/7f6b70ded6c34c43b284114c6ebb39cf/87383a81abf14df1b42b07def6ffb67f.jpg, createdBy=328c5246537, createdName=147d0f16m43暂无昵称, createdTime=Sat Aug 22 11:04:22 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=363274, encodeId=69bc3632e4fe, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/20/4198703c655298b79c00e85cf201319b.jpg, createdBy=b7312567629, createdName=病猫, createdTime=Wed Mar 20 23:34:45 CST 2019, time=2019-03-20, status=1, ipAttribution=)]
    2019-03-20 病猫

    学习

    0

相关指南

2016 ECIL-5建议：血液恶性肿瘤以及接受造血干细胞移植患者病毒性肝炎的管理

欧洲白血病感染会议(ECIL,European Conference on Infections in Leukaemia) · 2016-05-01